Create Account | Sign In: Author or Forum

Search Symptoms

Category: Family Medicine | Geriatrics | Gastroenterology | Neurology | Pharmacy | News

Back to Health News

Popular Heartburn Drugs Don’t Raise Risk of Alzheimer’s: Study

Last Updated: August 18, 2017.

Researchers say people need not avoid proton pump inhibitors like Nexium or Prilosec in hope of preventing dementia.

FRIDAY, Aug. 18, 2017 (HealthDay News) -- Widely used heartburn drugs called proton pump inhibitors do not appear to increase Alzheimer's disease risk, according to a new study.

Prilosec, Nexium and Prevacid are commonly used proton pump inhibitors.

Two previous studies reported a higher risk of dementia among people who took the drugs, which are commonly used by older adults. Proton pump inhibitors work by reducing the production of stomach acid.

But this new study found that use of the drugs was not associated with an increased risk of Alzheimer's, even among those who took a higher dose or used the drugs for more than three years.

The findings are from an analysis of data from Finland on nearly 71,000 Alzheimer's disease patients and nearly 283,000 people without the disease.

The study shows people need not avoid the drugs due to fears about developing Alzheimer's, said the University of Eastern Finland researchers led by Heidi Taipale, a postdoctoral researcher.

But long-term use should be carefully considered, because it has been linked with decreased calcium and vitamin B12 absorption and with serious intestinal infections, the study authors said in a university news release.

The researchers said more than one-third of older persons use proton pump inhibitors.

The study was published recently in the American Journal of Gastroenterology.

More information

The U.S. National Library of Medicine has more on proton pump inhibitors.

SOURCE: University of Eastern Finland, news release, Aug. 7, 2017


Previous: Less is More for the Adult Cholera Vaccine Next: 'Weekend Warriors' Tend to Wear White Collars

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: